Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Falls Church › NPI 1851319800
Lab

Quest Diagnostics Incorporated MD

Quest Diagnostics Incorporated MD was paid $936K by Medicaid between Sep 2019 and Jul 2020, across 17 billing codes. Its largest line is G0480, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed — 83% of everything it billed.

33Billing provider infoQUEST DIAGNOSTICS INCORPORATED MD
FALLS CHURCH, VA 22044
33aNPI1851319800assigned 07/18/2006
28Total paid$936K
24GClaims12,765
24DCodes billed17
24AFirst – last monthSep 2019 – Jul 2020
Compared with peers

Next to other Clinical Medical Laboratory providers in Virginia

Rank by total paid#21 of 78
Median peer was paid$37K
This provider vs. median25×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019656$21K
202012,109$914K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 83% 8,551 5,365 $778K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 13% 2,377 1,567 $122K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 1.8% 135 123 $17K
84443 Thyroid stimulating hormone (TSH) <1% 249 246 $4K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 530 492 $4K
80053 Comprehensive metabolic panel <1% 340 338 $4K
80061 Lipid panel <1% 220 220 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 62 59 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 130 130 $1K
80164 <1% 29 29 $385.41
80159 <1% 17 12 $308.55
84436 <1% 34 34 $229.16
5 more codes
80178 <1% 33 $214.17
84439 <1% 14 $123.90
84479 <1% 17 $107.78
83540 <1% 12 $76.20
82248 <1% 15 $73.80

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOWLES, CHARLES (VICE PRESIDENT)
Parent organizationQUEST DIAGNOSTICS INCORPORATED
Same official

Other billing entities under BOWLES, CHARLES

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.